| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/10/2007 | CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 01/10/2007 | CN1894261A Heterocyclic boronic acid compounds |
| 01/10/2007 | CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894212A Near-infrared fluorescent contrast medium |
| 01/10/2007 | CN1894190A Method for the production of tetrahydrogeranylacetone |
| 01/10/2007 | CN1893951A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/10/2007 | CN1893825A Substituted arylpyrazoles as parasiticidal agents |
| 01/10/2007 | CN1891696A Dissymmetrical diazo compounds, compositions comprising them, method of coloring, and device |
| 01/10/2007 | CN1891695A Symmetrical diazo compounds, compositions comprising them, method of coloring, and device |
| 01/09/2007 | US7160933 Image quality and durability; scratch and smudge resistance; water, humectant and particles comprised of water insoluble dye and polymer phase associated with costabilizer |
| 01/09/2007 | US7160918 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor (PAI-1) |
| 01/09/2007 | US7160915 N-methyl-substituted benzamidazoles |
| 01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160902 Amide derivatives and methods of their use |
| 01/09/2007 | US7160901 Antiproliferative agents; antitumor agents; kinase inhibitors |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| 01/09/2007 | US7160878 Substituted heterocyclic amides |
| 01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/09/2007 | US7160485 Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives, related anisotropic films, and methods for making |
| 01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007002462A2 Crystalline forms of mc4r agonist and process for synthesis |
| 01/04/2007 | WO2007002181A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 01/04/2007 | WO2007001818A2 Substituted isoindole-1,3-diones |
| 01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | WO2007000582A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | WO2006110816A3 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 01/04/2007 | WO2006067614A3 Heteroaromatic derivatives useful as anticancer agents |
| 01/04/2007 | WO2006020598A3 Amido compounds and their use as pharmaceuticals |
| 01/04/2007 | WO2006004684A8 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | US20070004920 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004786 (5S)-2-Amino-5-(1-ethyl-5-propionyl-1H-pyrrol-3-yl)-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-3,5-dihydro-4H-imidazol-4-one; to treat Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits |
| 01/04/2007 | US20070004779 Process for producing crystal |
| 01/04/2007 | US20070004778 New salts of omeprazole and esomeprazole i |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004763 Aminoquinoline and aminoquinazoline kinase modulators |
| 01/04/2007 | US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors |
| 01/04/2007 | US20070004757 Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 01/04/2007 | US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/04/2007 | US20070004754 Substituted pyrazoles |
| 01/04/2007 | US20070004753 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer |
| 01/04/2007 | US20070004750 such as 1-Benzyl-4-[(3,5-dimethylisoxazol-4-yl)carbonyl]piperazine, used for controlling fungi and insects; insecticides; fungicides |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004742 Arylpiperazinyl compounds |
| 01/04/2007 | US20070004730 e.g. 2-amino-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-5-pyridin-4-yl-3,5-dihydro-4H-imidazol-4-one; beta -amyloid deposits and neurofibrillary tangles blocking agent; neurodegenerative disorders, cognition activator; Alzheimer's disease, Down's Syndrome, senile dementia |
| 01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
| 01/04/2007 | US20070004719 Inhibitors of cytosolic phospholipase A2 |
| 01/04/2007 | US20070004717 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(-4-hydroxy-1-oxo-hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-methylbenzonitrile |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004701 6-Chloro-[1,1';4',1'']terphenyl-3-carboxylic acid (2-methoxy-pyrimidin-5-yl)-amide; inhibiting topoisomerase; multi-drug resistant cancers |
| 01/04/2007 | US20070004646 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/04/2007 | US20070004638 form C dihydrates; useful as they act directly on the pituitary gland cells to release growth hormone; storage stability |
| 01/04/2007 | US20070003873 High density recording media with modified recording layers of the invention provides better photoelectrical performance; high recording sensitivity and high carrier-to-noise ratio |
| 01/04/2007 | CA2613162A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | CA2612419A1 Process for preparing benzimidazole compounds |
| 01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | CA2611128A1 Novel indoline compounds |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1737925A1 New organic luminescent element |
| 01/03/2007 | EP1737851A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/03/2007 | EP1737846A1 New process for the preparation of diazine derivatives |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides |
| 01/03/2007 | EP1737843A1 Inhibitors of akt activity |
| 01/03/2007 | EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |
| 01/03/2007 | EP1737827A1 Process for preparing pyridazinone compounds |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737449A1 Pharmaceutical composition |
| 01/03/2007 | EP1737297A2 Imidazole compounds |
| 01/03/2007 | EP1654253B1 Substituted 3-pyrrolidin-indole derivatives |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1389617B1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 01/03/2007 | EP1223944B1 Thrombopoietin mimetics |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1890383A Hinge core mimetibodies, compositions, methods and uses |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1889949A PDK-1/Akt signaling inhibitors |
| 01/03/2007 | CN1887872A Tetrahydro isoquinoline derivative and its prepn process and medicine use |